Clinical Trial Update: A Multi-center Post-Market Surveillance Registry [Phase 4]

View source ↗

Summary

Post-market Phase 4 registry update to monitor outcomes in patients with coronary artery disease has completed across multiple centers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Cordis US Corp. | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED